George G. Zhanel spends much of his time researching Microbiology, Antibacterial agent, Pharmacology, Antibiotics and Drug resistance. His research integrates issues of Klebsiella pneumoniae and Escherichia coli in his study of Microbiology. His Antibacterial agent research integrates issues from Ciprofloxacin, Vancomycin and Tigecycline.
His Pharmacology study combines topics from a wide range of disciplines, such as Minimum inhibitory concentration, Anaerobic bacteria and Gatifloxacin. His research investigates the connection with Antibiotics and areas like Bacteria which intersect with concerns in Anti-Infective Agents, Combinatorial chemistry and Drug development. His studies deal with areas such as Glycylcycline and Antimicrobial as well as Drug resistance.
His main research concerns Microbiology, Antibiotics, Antibacterial agent, Streptococcus pneumoniae and Antimicrobial. His work carried out in the field of Microbiology brings together such families of science as Pseudomonas aeruginosa and Escherichia coli. George G. Zhanel has researched Antibiotics in several fields, including Efflux, Internal medicine, Pharmacology and Bacteria.
His Antibacterial agent study incorporates themes from Vancomycin, Minimum inhibitory concentration and Aminoglycoside. His Streptococcus pneumoniae research incorporates elements of Penicillin, Streptococcaceae and Serotype, Virology. The study incorporates disciplines such as Trimethoprim and Levofloxacin in addition to Ciprofloxacin.
Microbiology, Antimicrobial, Antibiotics, Pseudomonas aeruginosa and Antibiotic resistance are his primary areas of study. His research on Microbiology often connects related areas such as Efflux. George G. Zhanel has researched Antimicrobial in several fields, including Clostridium difficile, Ciprofloxacin, Fidaxomicin, Streptococcus pneumoniae and Diarrhea.
His research in Antibiotics intersects with topics in Adjuvant, Pharmacology, Acinetobacter baumannii and Bacteria. His Pseudomonas aeruginosa study also includes
The scientist’s investigation covers issues in Microbiology, Pharmacology, Antibiotics, Pseudomonas aeruginosa and Antibiotic resistance. His Microbiology research integrates issues from Efflux and Acinetobacter baumannii. His Pharmacology research includes themes of Ciprofloxacin, Tigecycline, Eravacycline, Meropenem and Avibactam.
George G. Zhanel combines subjects such as Dermatology, Vancomycin and Bacteria with his study of Antibiotics. His research integrates issues of Antibiotic exposure and Multiple drug resistance in his study of Antibiotic resistance. His work deals with themes such as Internal medicine and Enterobacteriaceae, which intersect with Antimicrobial.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Comparative review of the carbapenems.
George G Zhanel;Ryan Wiebe;Leanne Dilay;Kristjan Thomson.
Drugs (2007)
A Critical Review of the Fluoroquinolones
George G. Zhanel;George G. Zhanel;Kelly Ennis;Lavern Vercaigne;Andrew Walkty.
Drugs (2002)
Epidemic Clonal Groups of Escherichia coli as a Cause of Antimicrobial-Resistant Urinary Tract Infections in Canada, 2002 to 2004
James R. Johnson;James R. Johnson;Megan Menard;Megan Menard;Brian Johnston;Brian Johnston;Michael A. Kuskowski;Michael A. Kuskowski.
Antimicrobial Agents and Chemotherapy (2009)
Fluoroquinolone-Associated Tendinopathy: A Critical Review of the Literature
Yasmin Khaliq;George G. Zhanel.
Clinical Infectious Diseases (2003)
Clinical Practice Guidelines for Hospital-Acquired Pneumonia and Ventilator-Associated Pneumonia in Adults
Coleman Rotstein;Gerald Evans;Abraham Born;Ronald Grossman.
Canadian Journal of Infectious Diseases & Medical Microbiology (2008)
Review of macrolides and ketolides: focus on respiratory tract infections.
George G. Zhanel;Maria Dueck;Daryl J. Hoban;Lavern M. Vercaigne.
Drugs (2001)
The glycylcyclines: a comparative review with the tetracyclines.
George G Zhanel;Kristen Homenuik;Kim Nichol;Ayman Noreddin.
Drugs (2004)
Ceftazidime-avibactam: a novel cephalosporin/β-lactamase inhibitor combination.
George G. Zhanel;George G. Zhanel;Christopher D. Lawson;Heather Adam;Heather Adam;Frank Schweizer.
Drugs (2013)
Streptococcus pneumoniae: epidemiology and risk factors, evolution of antimicrobial resistance, and impact of vaccines.
Joseph P Lynch;George G Zhanel.
Current Opinion in Pulmonary Medicine (2010)
Antibiotic resistance in Escherichia coli outpatient urinary isolates: final results from the North American Urinary Tract Infection Collaborative Alliance (NAUTICA).
George G. Zhanel;Tamiko L. Hisanaga;Nancy M. Laing;Melanie R. DeCorby.
International Journal of Antimicrobial Agents (2006)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of Manitoba
University of Manitoba
Public Health Agency of Canada
University of California, Los Angeles
University of Manitoba
Public Health Agency of Canada
University of Manitoba
University of Toronto
University of Toronto
University of Minnesota
Beijing Institute of Technology
Chapman University
Leiden University
Hongik University
Chinese Academy of Sciences
University of Queensland
Dalhousie University
University of Leeds
University of California, San Diego
Universität Hamburg
University of Sheffield
Ghent University
Goddard Space Flight Center
Stockholm University
University of North Carolina at Greensboro
University of Bologna